Darya Chudova - 01 Jun 2025 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Chief Technology Officer
Signature
/s/ John G. Saia, as attorney-in-fact for Darya Chudova
Issuer symbol
GH
Transactions as of
01 Jun 2025
Net transactions value
-$6,540
Form type
4
Filing time
02 Jun 2025, 18:03:07 UTC
Previous filing
19 May 2025
Next filing
02 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Chudova Darya Chief Technology Officer 3100 HANOVER STREET, PALO ALTO /s/ John G. Saia, as attorney-in-fact for Darya Chudova 02 Jun 2025 0001977179

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Options Exercise $0 +316 +0.4% $0.000000 79,973 01 Jun 2025 Direct
transaction GH Common Stock Tax liability $6,540 -161 -0.2% $40.62 79,812 01 Jun 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Restricted Stock Units Options Exercise $0 -316 -50% $0.000000 316 01 Jun 2025 Common Stock 316 $0.000000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2 The restricted stock unit award was granted on November 2, 2021, of which 3,157 shares were outstanding on May 3, 2023, when the reporting person was elected as an officer. These shares vest in equal quarterly installments on the anniversary of September 1, 2022 and fully vest on September 1, 2025.
F3 Not applicable for Restricted Stock Units.

Remarks:

Table I includes 859 shares acquired under Guardant Health's Employee Stock Purchase Plan on 5/14/2025.